| Literature DB >> 29936182 |
Ismael Al-Ramahi1, Boxun Lu2, Simone Di Paola3, Kaifang Pang4, Maria de Haro1, Ivana Peluso3, Tatiana Gallego-Flores1, Nazish T Malik1, Kelly Erikson1, Benjamin A Bleiberg1, Matthew Avalos1, George Fan1, Laura Elizabeth Rivers1, Andrew M Laitman4, Javier R Diaz-García1, Marc Hild5, James Palacino5, Zhandong Liu4, Diego L Medina3, Juan Botas6.
Abstract
Discriminating transcriptional changes that drive disease pathogenesis from nonpathogenic and compensatory responses is a daunting challenge. This is particularly true for neurodegenerative diseases, which affect the expression of thousands of genes in different brain regions at different disease stages. Here we integrate functional testing and network approaches to analyze previously reported transcriptional alterations in the brains of Huntington disease (HD) patients. We selected 312 genes whose expression is dysregulated both in HD patients and in HD mice and then replicated and/or antagonized each alteration in a Drosophila HD model. High-throughput behavioral testing in this model and controls revealed that transcriptional changes in synaptic biology and calcium signaling are compensatory, whereas alterations involving the actin cytoskeleton and inflammation drive disease. Knockdown of disease-driving genes in HD patient-derived cells lowered mutant Huntingtin levels and activated macroautophagy, suggesting a mechanism for mitigating pathogenesis. Our multilayered approach can thus untangle the wealth of information generated by transcriptomics and identify early therapeutic intervention points.Entities:
Keywords: Huntington disease; NFKB; RAC2; actin cytoskeleton; autophagy; calcium signaling; compensatory changes; inflammation; synaptic biology; transcriptome
Mesh:
Substances:
Year: 2018 PMID: 29936182 PMCID: PMC6082401 DOI: 10.1016/j.cels.2018.05.010
Source DB: PubMed Journal: Cell Syst ISSN: 2405-4712 Impact factor: 10.304